RK
Rahulkumar Kantibhai Sisodiya
About Rahulkumar Kantibhai Sisodiya
Data last updated:
Rahulkumar Kantibhai Sisodiya is a Designated Partner at Radeep Pharma Llp (since 2021). The companies operate in Chemicals and Materials and Healthcare. Earlier, Rahulkumar Kantibhai Sisodiya was a Director at Trio Healthline Private Limited (2021–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 29 Nov 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Jun 2021 | 2021 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rahulkumar Kantibhai Sisodiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anvarhusen Bangli | 11164973 | Radeep Pharma Llp | Designated Partner |
| Pardeep Sangwan | 09416397 | Radeep Pharma Llp | Designated Partner |
| Piyush Kumar Hiralal Parmar | 08718953 | Radeep Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rahulkumar Kantibhai Sisodiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rahulkumar Kantibhai Sisodiya
Rahulkumar Kantibhai Sisodiya currently holds 1 directorship: Radeep Pharma Llp (Designated Partner, since 29 Nov 2021).
Rahulkumar Kantibhai Sisodiya was first appointed on 18 Jun 2021 as Director at Trio Healthline Private Limited.
Rahulkumar Kantibhai Sisodiya held 1 earlier board appointment: Trio Healthline Private Limited (Director, 18 Jun 2021 to 18 Jan 2023).
The current boards of Rahulkumar Kantibhai Sisodiya's companies include Anvarhusen Bangli (Radeep Pharma Llp), Pardeep Sangwan (Radeep Pharma Llp), Piyush Kumar Hiralal Parmar (Radeep Pharma Llp).